Consolidated Statements of Operations (Unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Product revenues	$ 5,781	$ 5,974
Service revenues	6,840	2,043
Total revenues	12,621	8,017
Cost of sales	4,885	2,295
Gross profit	7,736	5,722
Operating expenses:
Selling, general and administrative	6,111	4,751
Research and development	2,178	1,780
Change in fair value of contingent consideration	2,556
Total operating expenses	10,845	6,531
Operating loss	(3,109)	(809)
Interest expense, net	(126)	(14)
Other loss, net	(70)	(83)
Loss before taxes	(3,305)	(906)
Income tax benefit (expense), net	88	(11)
Net loss	(3,217)	(917)
Less: Net income attributable to non-controlling interests	25
Net loss attributable to ChyronHego shareholders	$ (3,242)	$ (917)
Net loss per share attributable to ChyronHego shareholders - basic (in Dollars per share)	$ (0.10)	$ (0.05)
Net loss per share attributable to ChyronHego shareholders - diluted (in Dollars per share)	$ (0.10)	$ (0.05)
Weighted average shares outstanding:
Basic (in Shares)	31,118	17,362
Diluted (in Shares)	31,118	17,362